inflammatory regulators, which may lead to vasodilation, increased capillary permeability and hypotension leading to multiple organ failure and death. 3 Although the development of new and more effective antibiotics over the past decade has improved the prognosis of sepsis, neutralization of inflammation is crucial to prevent the most severe consequences of this condition. 4 The use of anti-inflammatory cytokines as a novel therapeutic concept for the treatment of endotoxemia has been developed.
However, although the knowledge about variations in inflammationassociated markers during endotoxemia has been well-addressed, the alterations and dynamics of inflammatory cytokines/chemokines during early phase are still not clear and are worth elucidating, as they may provide insights for new therapeutic targets, potentially inhibiting progression into septic shock. Treatments at early phase of endotoxemia are much more effective.
The use of nonhuman primates (NHPs) is considered a favorable choice for basic and preclinical models of sepsis primarily due to their phylogenetic proximity to humans. The primary goal of this study was to develop a rhesus macaque model of Gram-negative sepsis in order to investigate changes in the levels of inflammatory cytokines/chemokines as well as of other inflammatory markers during the early phase (within 8 hours) of endotoxemia in rhesus macaques.
| MATERIAL S AND ME THODS

| Ethics statement
This study was performed in accordance with the Guide for the 
| Animals
Four adult male (6-7 years old) rhesus macaques (Macaca mulatta), weighing 6.0-11 kg, were facilitated by the Caribbean Primate Research Center. Prior to inclusion in the experiment, the monkeys received a physical examination and were tested for hematological, serological, and microbiological abnormalities. Only the animals confirmed healthy by a veterinarian were included.
| Bacterial culture
The Escherichia coli strain 086a: K61 serotype used for sepsis induction was purchased from the American Type Culture Collection ATCC (ATCC 33985). Prior to the experiment a fresh E. coli culture was set up in Luria Broth (LB) agar and cultured overnight at 37°C.
The following day a single colony was cultured in 300 mL of LB broth for 16-18 hours, a final concentration of 1 x 10 10 CFU/mL was harvested and washed three times to remove free endotoxin.
| Animal preparation and establishment of baseline physiological parameters
The day before the procedure, monkeys were sedated with ketamine hydrochloride (10 mg/kg) (AST Pharma) intramuscularly and transported to a holding room for overnight fasting. The day of the procedure monkeys were sedated with ketamine as described above, induced under anesthesia with inhaled isoflurane gas (1%-5%) via mask, then intubated and maintained on isoflurane for the remainder of the procedure. The cephalic vein was cannulated and used for intravenous (IV) infusion of live E. coli and isotonic saline (0.9%NaCl) containing 2.5% Dextrose at a rate of 3.3 mL/kg/h. Animals were connected to a BIONET monitor for one hour prior to sepsis induction. The levels of body temperature (BT), heart rate (HR), respiratory rate (RR), and mean arterial blood pressure (MAP), were recorded for establishment of baseline values. Veterinary staff continuously monitored animals throughout the procedure.
| E. coli infusion and blood collection
Individual body weights were used to calculate the E. coli dose (10 10 CFU/kg), which was previously established as lethal for this species. 5 Sterile isotonic saline was used to adjust to a final volume of 50 mL and given as an IV constant rate infusion (CRI) (0.42 mL/ min for 2 hours). Eight hours following the bacterial infusion, animals were euthanized in accordance with the AVMA Guidelines for the Euthanasia of Animals (2013). Gross necropsy was completed immediately following euthanasia. Following E. coli infusion, 5 mL of blood were collected from the femoral vein using a 20-gauge Vacutainer needle into heparinized tubes at 0, 30 minutes, 2, 4, 6 and 8 hours.
Blood samples were centrifuged at 450 rcf x 10 minutes and the plasma was collected. Prior to centrifugation, an aliquot of 100 μL from each blood sample was allotted for determining bacteremia levels.
| Bacteremia and endotoxemia assessment
To assess bacteremia, the allotted blood samples were diluted with equal volume of sterile PBS, spread onto LB agar plates, and cultured overnight at 37°C. After incubation, colonies were counted, and the total CFU/mL was calculated and adjusted based on the dilution factor. Endotoxin levels were assessed directly from plasma samples using the Chromogenic Limulus Amoebocyte Lysate QCL-1000 Assay (Lonza, Walkersville, MD) following the manufacturer's instructions.
| C-reactive protein levels (CRP) and procalcitonin assay (PCT)
Plasma samples were tested for the presence of CRP and PCT.
Quantification of CRP levels was performed at a local clinical laboratory (Martin Clinical Lab, Bayamon, PR) using an Architect c8000 Clinical Chemical Analyzer (Abbot, Illinois, US). Procalcitonin levels were determined as per the manufacturer's instructions using a Human Procalcitonin ELISA kit (Abcam, UK, ab100630).
| Cytokine and chemokine profiling
Plasma cytokine and chemokine levels were determined using Luminex technology employing established protocols for old world primates. 6 The assay included evaluation of interleukin-6 (IL-6), gamma interferon (IFN-γ), tumor necrosis factor-α (TNF-α), 
| Statistical analysis
All determinations of cytokines/chemokines, PCT and CRP were performed in duplicate and the results are expressed as mean value (pg/mL or mg/dL) for each determination. Significance was determined using a student's t test for single comparison or analysis of variance test for multiple comparisons, with a P < .05 established as significant (GraphPad Prism 6.0 software).
| RE SULTS AND D ISCUSS I ON
To better understand the complexity of pathogenesis of sepsis in humans it is necessary to establish experimental animal models with physiological functions and anatomical features comparable to humans. Nonhuman primates (NHP) display identical cardiopulmonary anatomy and physiology, as well as host response to infection. 7 In particular, rhesus macaques have shown to be similar to the responses of humans to Gram-negative sepsis. 8 Moreover, the outbred nature of monkeys is more representative of the human population as a whole. Thus, rhesus macaque constitutes a realistic model to study the acute inflammatory process of sepsis after live bacteria infusion.
Compared to humans, NHPs are notably less sensitive to the lethal effects of LPS, as has been documented in rodents. 9 Boluses of 10-20 mg/kg of LPS are usually required to develop endotoxic shock in NHPs. 10 This dose is > 1 000 000 times greater than the typical dose of LPS (2-4 ng/kg), which has been used in human volunteers to induce symptoms and release detectable levels of TNF-α into the circulation. 11 However, the sepsis model based on the bolus injection with LPS commonly induces an immediate hypo-dynamic cardiovascular state as well as an overwhelming innate immunity response, failing to reproduce the hemodynamic changes observed in human sepsis. 9, 12 In our study sepsis induction was achieved by introducing live E. coli by CRI to mimic human bacterial exposure.
At baseline the BT, HR and RR ranged between 36.1-37.7°C (median 37°C), 104-124 beat/min (median 121 beats/min), and 16-31 breaths/min (median 21 breaths/min), respectively. The MAP ranged between 46-65 mm Hg (median 50.5 mm Hg). Low values for MAP during baseline are associated with oscillometric monitoring of blood pressure (BP). Recent literature showed that oscillometric BP measurements underestimate MAP values in rhesus macaque when compared to direct BP measurement. 13, 14 We were unable to include a mock-infected group. However, considering the high immune response heterogeneity of this model, using preinfusion physiological parameters values as each individual controls, appropriately achieve the goal of this work, and accurately measured the dynamics of targeted immune parameters during disease progression.
Two hours after bacterial infusion completion animals BS81
and CB22P showed minor episodes of bradycardia and hypotension. At the conclusion of the procedure, the HR and BP parameters were similar or higher than baseline (Table 1) Respiratory rate (rpm) 31 2 Bacteremia was detectable in three animals (BS81, 702 and MA107) from 30 minutes to 2 hours after E. coli infusion, but not thereafter. In contrast, bacteremia of CB22P was steadily increasing and remained high through the end of the procedure ( Figure 1A ).
Undetectable bacteremia in three animals suggests that the bacteria failed to colonize or replicate inside the animals and was rapidly lysed by the complement system, as it has been previously reported for high bacterial inoculum to induced sepsis. 15 In that regard, and this assumption. C-reactive protein, produced by the liver, is classified as an acute phase reactant, meaning that its levels should rise in response to ongoing inflammation. 16 Procalcitonin serves as a biomarker of high specificity for bacterial infections and is a good predictor of bacterial sepsis in humans. 17 The finding that all animals showed elevating levels of CRP and PCT ( Figure 1D ) despite that three of four animals had no detectable bacteremia, reinforces the validity of these two parameters as functional predictors of an ongoing inflammatory process due to bacterial infection in rhesus macaques.
We also evaluated the levels of several plasma cytokines and chemokines in our experiment. Tumor necrosis factor-α, a component of the acute phase of systemic inflammation, is primarily produced by monocytes and macrophages, 18 Figure 2B ). Interestingly, although the four animals showed a similar IL-6 dynamics, we noticed that rhesus macaques 702 and MA107, which died shortly before completion of the study, had 120-fold increase in IL-6 when compared to rhesus macaques BS81 and CB22P (animals with no clinical symptom of septic shock). These results are in agreement with studies that showed elevated levels of IL-6 in human sepsis in correlation with the occurrence of multiple organ failure and septic shock and mortality. 22 Another cytokine with a similar dynamic to IL-6 was IL-12p40
( Figure 2C ). Interleukin-12p40 was detectable in all animals at 4 hours of E. coli infusion as compared to baseline (66 196.5 ± 52 874 pg/ mL; P < .0001), and peaked at 6 hours (117 546.5 ± 104 479.9 pg/ mL). Collectively the rhesus macaques that died (702 and MA107) had 30-fold more IL-12p40 than rhesus macaques BS81 and CB22P.
The high levels of plasma IL-12p40 are consistent with our previous findings in a mouse model of septic shock. 23 Interleukin-12p40 is a subunit essential for biological activity of IL-12p70 and has shown to be a subunit of another composite cytokine designated IL-23. 24 Both, IL-12 and IL-23, induce the production of IFN-γ from both activated or memory CD4 + T-lymphocytes and have been found increased in patients with sepsis, 25, 26 suggesting a role in sepsis. Consistent with these observations, we also found high concentrations of IFN-γ in all shock. 27 Moreover, our observation that rhesus macaques 702 and MA107 showed a 25-fold increase in IFN-γ when compared to BS81 and CB22P ( Figure 2D ) is also consistent with previous reports that demonstrated enhanced and persistent levels in patients who died of sepsis. 26 Interestingly, IL-1Ra, a major anti-inflammatory cytokine 28 that modulates the action of IL-1, 29 was also found at detectable levels in all animals from 2 hours after E. coli infusion (25 820.75 ± 15 430 pg/ mL) and increased gradually throughout the experiment reaching mean concentrations of 287 211.00 ± 288 683 pg/mL at the end of the study (Figure 2E ). It has been reported that IL-1Ra along with TNF-α, amplies the inflammatory cascades by activating macrophages to secrete other proinflammatory cytokines and inflammatory mediators, leading to sepsis-mediated organ dysfunction. 30 High concentrations of IL-1Ra have been also found in septic patients and have also been correlated with disease severity in humans. 31 Chemokines are a family of chemoattractant cytokines that play a central role in recruiting immune effector cells to a site of 
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